Andreas Möck

3.6k total citations
46 papers, 1.7k citations indexed

About

Andreas Möck is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Andreas Möck has authored 46 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Oncology and 12 papers in Cancer Research. Recurrent topics in Andreas Möck's work include Cancer Genomics and Diagnostics (7 papers), Glioma Diagnosis and Treatment (6 papers) and Head and Neck Cancer Studies (4 papers). Andreas Möck is often cited by papers focused on Cancer Genomics and Diagnostics (7 papers), Glioma Diagnosis and Treatment (6 papers) and Head and Neck Cancer Studies (4 papers). Andreas Möck collaborates with scholars based in Germany, United States and Greece. Andreas Möck's co-authors include G.W. Nyce, Eric F. Connor, James L. Hedrick, Matthew Myers, G. Peters, Thierry Glauser, Robert M. Waymouth, Christel Herold‐Mende, David N. Louis and John DeWitt and has published in prestigious journals such as Journal of the American Chemical Society, Bioinformatics and Macromolecules.

In The Last Decade

Andreas Möck

43 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Möck Germany 18 731 542 472 272 269 46 1.7k
Fuchuan Li China 24 235 0.3× 68 0.1× 13 0.0× 64 0.2× 990 3.7× 65 1.7k
Hang Su China 23 158 0.2× 47 0.1× 33 0.1× 128 0.5× 1.3k 4.7× 75 2.7k
Anjali Shiras India 23 87 0.1× 306 0.6× 10 0.0× 122 0.4× 1.0k 3.9× 43 1.8k
Zhen Xing China 23 86 0.1× 197 0.4× 13 0.0× 128 0.5× 1.3k 4.8× 93 2.1k
Kazuma Takase Japan 22 59 0.1× 562 1.0× 155 0.3× 73 0.3× 923 3.4× 64 1.8k
Yongguang Gao China 21 97 0.1× 238 0.4× 8 0.0× 63 0.2× 917 3.4× 49 1.7k
Kouji Iida Japan 27 87 0.1× 412 0.8× 117 0.2× 127 0.5× 1.4k 5.0× 112 2.6k
Chang‐Cheng Liu China 16 373 0.5× 48 0.1× 9 0.0× 95 0.3× 1.1k 4.1× 42 1.4k
Shuo Yang China 28 213 0.3× 212 0.4× 8 0.0× 202 0.7× 1.2k 4.5× 80 2.3k

Countries citing papers authored by Andreas Möck

Since Specialization
Citations

This map shows the geographic impact of Andreas Möck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Möck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Möck more than expected).

Fields of papers citing papers by Andreas Möck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Möck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Möck. The network helps show where Andreas Möck may publish in the future.

Co-authorship network of co-authors of Andreas Möck

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Möck. A scholar is included among the top collaborators of Andreas Möck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Möck. Andreas Möck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keyl, Julius, Andreas Möck, Liliana H. Mochmann, et al.. (2025). Neural interaction explainable AI predicts drug response across cancers. NAR Cancer. 7(3). zcaf029–zcaf029.
2.
Jurinović, Vindi, Markus Albertsmeier, Hans Roland Dürr, et al.. (2025). First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysis. Journal of Cancer Research and Clinical Oncology. 151(4). 150–150.
3.
Liokatis, Paris, Wenko Smolka, Sven Otto, et al.. (2024). Prognostic role of lymph node micrometastasis in oral and oropharyngeal cancer: A systematic review. Oral Oncology. 154. 106808–106808. 3 indexed citations
4.
Kumbrink, Jörg, et al.. (2024). The Role of Glucose-6-Phosphate Dehydrogenase in Skin Cancer Metabolism: A Paradigm Shift in Treatment Approaches. Cancers. 17(1). 48–48. 1 indexed citations
5.
Möck, Andreas, et al.. (2023). Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing. Scientific Reports. 13(1). 2378–2378. 13 indexed citations
6.
Teleanu, Maria‐Veronica, Carmina Teresa Fuß, Nagarajan Paramasivam, et al.. (2023). Targeted therapy of advanced parathyroid carcinoma guided by genomic and transcriptomic profiling. Molecular Oncology. 17(7). 1343–1355. 7 indexed citations
7.
Renner, Marcus, Małgorzata Oleś, Nagarajan Paramasivam, et al.. (2023). 1936P Targeted therapy of desmoplastic small round cell tumor guided by multilayered molecular profiling. Annals of Oncology. 34. S1040–S1040. 1 indexed citations
8.
Schulze, Markus, Lars Buschhorn, Andreas Möck, et al.. (2023). Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and Experiences. Breast Care. 19(1). 10–17. 1 indexed citations
9.
Schnabel‐Besson, Elena, Maximilian Knoll, Christian Schwager, et al.. (2021). Prognostic Value of microRNA-221/2 and 17-92 Families in Primary Glioblastoma Patients Treated with Postoperative Radiotherapy. International Journal of Molecular Sciences. 22(6). 2960–2960. 6 indexed citations
10.
Yu, Tao, Junguo Cao, Mahmoud Moustafa, et al.. (2021). Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo. Cancers. 13(23). 5898–5898. 10 indexed citations
11.
Moratin, Julius, Andreas Möck, Karl Metzger, et al.. (2021). Digital Pathology Scoring of Immunohistochemical Staining Reliably Identifies Prognostic Markers and Anatomical Associations in a Large Cohort of Oral Cancers. Frontiers in Oncology. 11. 712944–712944. 13 indexed citations
12.
Möck, Andreas, Carmen Rapp, Steffen Dettling, et al.. (2020). Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival. Clinical Cancer Research. 26(9). 2231–2243. 23 indexed citations
13.
14.
15.
Akbaba, Sati, Andreas Möck, Thomas Held, et al.. (2019). Treatment Outcome of a Combined Dose-Escalated Treatment Regime With Helical TomoTherapy® and Active Raster-Scanning Carbon Ion Boost for Adenocarcinomas of the Head and Neck. Frontiers in Oncology. 9. 755–755. 2 indexed citations
16.
Möck, Andreas, Stefanie Zschäbitz, Romy Kirsten, et al.. (2019). Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancers. Cancer Immunology Immunotherapy. 68(12). 2005–2014. 27 indexed citations
17.
Möck, Andreas, Suzanne Murphy, James Morris, et al.. (2017). CVE: an R package for interactive variant prioritisation in precision oncology. BMC Medical Genomics. 10(1). 37–37. 8 indexed citations
18.
Möck, Andreas & Christel Herold‐Mende. (2015). Non-invasive glioblastoma immunoprofiling by printed peptide arrays. OncoImmunology. 5(2). e1069941–e1069941. 3 indexed citations
19.
Möck, Andreas, Sara Chiblak, & Christel Herold‐Mende. (2014). Lessons we Learned from High-Throughput and Top-Down Systems Biology Analyses about Glioma Stem Cells. Current Pharmaceutical Design. 20(1). 66–72. 3 indexed citations
20.
Herold‐Mende, Christel & Andreas Möck. (2014). Microenvironment and Brain Tumor Stem Cell Maintenance: Impact of the Niche. Anti-Cancer Agents in Medicinal Chemistry. 14(8). 1065–1074. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuchuan Li Breakdown of academic impact, for papers by Hang Su Breakdown of academic impact, for papers by Anjali Shiras Breakdown of academic impact, for papers by Zhen Xing Breakdown of academic impact, for papers by Kazuma Takase Breakdown of academic impact, for papers by Yongguang Gao Breakdown of academic impact, for papers by Kouji Iida Breakdown of academic impact, for papers by Chang‐Cheng Liu Breakdown of academic impact, for papers by Shuo Yang
Rankless by CCL
2026